𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The role of an international apheresis registry for the establishment of apheresis therapy

✍ Scribed by BG Stegmay; L Guillevin; JM Korach; G Rock; R Norda; W Ramlow

Book ID
111333792
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
93 KB
Volume
9
Category
Article
ISSN
1091-6660

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The Italian Registry for Therapeutic Aph
The Italian Registry for Therapeutic Apheresis. A report from the Apheresis Study Group of the Italian Society of Nephrology
✍ Stefano Passalacqua; Emiliano Staffolani; Ghil Busnach; Dario Roccatello; Sonia πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 80 KB πŸ‘ 1 views

## Abstract Many clinical indications and different technical issues have been reported on therapeutic apheresis: much criticism has also been recorded in several instances, mainly due to the lack of large clinical trials to validate collected data. A Registry where all the available data can be or

The Italian registry of therapeutic aphe
The Italian registry of therapeutic apheresis: Granulocyte–monocyte apheresis in the treatment of inflammatory bowel disease. A multicentric study
✍ Stefano Passalacqua; Pietro Manuel Ferraro; Giampaolo Bresci; Valeria D'Ovidio; πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 172 KB πŸ‘ 1 views

## Abstract Leukocytes are thought to play an important role in the pathogenesis of inflammatory bowel diseases; granulocyte–monocyte adsorptive (GMA) apheresis, an extracorporeal technique aimed at removing activated circulating leukocytes from the blood, may represent a safe and effective therape

Apheresis medicine state of the art in 2
Apheresis medicine state of the art in 2010: American Society for Apheresis fifth special edition of the Journal of Clinical Apheresis
✍ Jeffrey L. Winters πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 55 KB

## Abstract The quality of evidence supporting the use of apheresis in the treatment of individual diseases and disorders is often limited. For most diseases and disorders, randomized controlled trials of the use of apheresis have not been performed and for many, due to rarity of the condition, it